Adherence to HIV postexposure prophylaxis: A systematic review and meta-analysis

AIDS

Volumn 28, Issue 18, 2014, Pages 2721-2727

  Ford, Nathan ^a   Irvine, Cadi ^a   Shubber, Zara ^b   Baggaley, Rachel ^a   Beanland, Rachel ^a   Vitoria, Marco ^a   Doherty, Meg ^a   Mills, Edward J ^c   Calmy, Alexandra ^d  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Adherence; Antiretrovirals; Nonoccupational exposure; Occupational exposure; Postexposure prophylaxis; Sexual assault

Indexed keywords

ANTIRETROVIRUS AGENT; INTEGRASE INHIBITOR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR;

AGE; COHORT ANALYSIS; DRUG WITHDRAWAL; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTENTION TO TREAT ANALYSIS; MEDICATION COMPLIANCE; META ANALYSIS; OCCUPATIONAL EXPOSURE; PATIENT COMPLIANCE; PATIENT SELECTION; POST EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SECONDARY PREVENTION; SEROCONVERSION; SEXUAL ASSAULT; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HIV INFECTIONS; INFANT; MALE; MIDDLE AGED; PRESCHOOL CHILD; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; INFANT; MALE; MEDICATION ADHERENCE; MIDDLE AGED; POST-EXPOSURE PROPHYLAXIS; YOUNG ADULT;

EID: 84927754087     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000505     Document Type: Review

References (26)

1. Centers for Disease C, Prevention. Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood-France, United Kingdom, and United States, January 1988-August 1994. MMWR Morb Mort Wkly Rep 1995; 44:929-933.
2. Black RJ. Animal studies of prophylaxis. Am J Med 1997; 102 (5B):39-44.
3. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331:1173-1180.
4. Chacko L, Ford N, Sbaiti M, Siddiqui R. Adherence to HIV postexposure prophylaxis in victims of sexual assault: A systematic review and meta-analysis. Sex Transm Infect 2012; 88:335-341.
5. Oldenburg CE, Barnighausen T, Harling G, Mimiaga MJ, Mayer KH. Adherence to post-exposure prophylaxis for nonforcible sexual exposure to HIV: A systematic review and meta-analysis. AIDS Behav 2013; 18:217-225.
6. Young TN, Arens FJ, Kennedy GE, Laurie JW, Rutherford G. Antiretroviral postexposure prophylaxis (PEP) for occupational HIV exposure. Cochrane Database Syst Rev 2007:CD002835.
7. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-188.
8. Freeman MFTJ. Transformations Related to the Angular and the Square Root. Ann Math Stat 1950; 21:607-611.
9. Miller J. The inverse of the Freeman-Tukey double arcsine transformation. Am Stat 1978; 32:138.
10. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-560.
11. Olshen E, Hsu K, Woods ER, Harper M, Harnisch B, Samples CL. Use of human immunodeficiency virus postexposure prophylaxis in adolescent sexual assault victims. Arch Pediatr Adoles Med 2006; 160:674-680.
12. Abrahams N, Jewkes R, Lombard C, Mathews S, Campbell J, Meel B. Impact of telephonic psycho-social support on adherence to postexposure prophylaxis (PEP) after rape. AIDS Care 2010; 22:1173-1181.
13. Bentz L, Enel P, Dunais B, Durant J, Poizot-Martin I, Tourette- Turgis C, et al. Evaluating counseling outcome on adherence to prophylaxis and follow-up after sexual HIV-risk exposure: A randomized controlled trial. AIDS Care 2010; 22:1509-1516.
14. Roland ME, Neilands TB, Krone MR, Coates TJ, Franses K, Chesney MA, et al. A randomized noninferiority trial of standard versus enhanced risk reduction and adherence counseling for individuals receiving postexposure prophylaxis following sexual exposures to HIV. Clin Infect Dis 2011; 53:76-83.
15. Christofides NJ, Muirhead D, Jewkes RK, Penn-Kekana L, Conco DN. Women's experiences of and preferences for services after rape in South Africa: interview study. BMJ 2006; 332:209-213.
16. Ko NY, Yeh SH, Tsay SL, Ma HJ, Chen CH, Pan SM, et al. Intention to comply with postexposure management among nurses exposed to blood and body fluids in Taiwan: Application of the theory of planned behaviour. J Hosp Infect 2011; 77:321- 326.
17. Kuhar DT, Henderson DK, Struble KA, Heneine W, Thomas V, Cheever LW, et al. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis. Infect Control Hosp Epidemiol 2013; 34:875- 892.
18. Lowenthal E, Bakeera-Kitaka S, Marukutira T, Chapman J, Goldrath K, Ferrand R. Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: A review of emerging challenges. Lancet Infect Dis 2014; 14:627-639.
19. Barnighausen T, Chaiyachati K, Chimbindi N, Peoples A, Haberer J, Newell ML. Interventions to increase antiretroviral adherence in sub-Saharan Africa: A systematic review of evaluation studies. Lancet Infect Dis 2011; 11:942-951.
20. Ramjam RCA, Vitoria M, Mills EJ, Hill A, Cooke G, Ford N. Patient and programme impact of fixed-dose combination antiretroviral therapy: A systematic review and meta-analysis. Trop Med Int Health 2014; 19:501-513.
21. Greub G, Gallant S, Zurn P, Vannotti M, Bürgisser P, Francioli P, et al. Spare nonoccupational HIV postexposure prophylaxis by active contacting and testing of the source person. AIDS 2002; 16:1171-1176.
22. Kim JC, Askew I, Muvhango L, Dwane N, Abramsky T, Jan S, et al. Comprehensive care and HIV prophylaxis after sexual assault in rural South Africa: The Refentse intervention study. BMJ 2009; 338:b515.
23. Al-Dakkak I, Patel S, McCann E, Gadkari A, Prajapati G, Maiese EM. The impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy: A systematicreview and meta-analysis. AIDS Care 2013; 25:400-414.
24. Nachega JB, Parienti JJ, Uthman OA, Gross R, Dowdy DW, Sax PE, et al. Lower pill burden and once-daily dosing antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials. Clin Infect Dis 2014; 58:1297-1307.
25. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 2012; 367:399- 410.
26. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.